African trypanosomes cause debilitating disease in humans and livestock and constitute a major hindrance to agricultural development in sub-Saharan Africa. The surface of these unicellular parasites is coated almost entirely by a molecule known as the variant surface glycoprotein (VSG) (8, 9) , which is the target of potent B-cell responses in infected individuals (8) . These responses, coupled with the capacity of the parasite to express a large number of different VSG variants (30) , are believed to be responsible for the successive waves of parasitemia that are characteristic of the disease.
The basis of VSG antigenic variation has been established in Trypanosoma brucei to be transcriptional switching between different VSG genes (reviewed previously [12] ). Parasitemia with each variant is controlled by the antibody response of the host to the VSG, and in cattle, most of the antibody made during infection is specific for determinants of the molecule that are exposed on the surface of the parasite (19) . Accordingly, homology between VSGs is largely confined to the carboxy terminus of the molecule (23) , which on the live parasite is concealed from the immune system. Although optimum VSG-specific antibody responses in mice infected with Trypanosoma brucei rhodesiense are T cell dependent (22) , proliferative T-cell responses to VSG are not detected in this species or in cattle during or after infection (13, 22) . However, recent observations have confirmed that VSG-specific T-cell responses can be detected in mice infected with T. b. rhodesiense by measurement of cytokines in cultures of lymphocyte populations with the antigen (28) . Responses are restricted to certain immunological compartments and are most evident in the peritoneal cavity.
Cattle infected with the ILTat 1.3 clone of T. brucei make potent antibody responses to the clonotypic VSG molecule (19, 20) . Immunization with irradiated ILTat 1.3 parasites results in complete protection against homologous challenge that correlates with serum antibody activity and is essentially specific for antigenic determinants of VSG that are exposed on the intact trypanosome (19) . In contrast, antibody induced by purified ILTat 1.3 VSG formulated in adjuvants is largely directed at t ILRAD publication 1299. hidden determinants (19) . Immunization with purified antigen nonetheless induces protective immunity that is not correlated with the vigor of the antibody response (33) . Although proliferative T-cell responses to sonicated trypanosome lysates were detected in some of these cattle, the specificity of these responses was not determined. A possible role for VSGspecific T-cell responses in clearance of successive parasitemic waves in cattle therefore remains to be established.
A recent analysis of the crystal structures of two VSG molecules related to ILTat 1.3 has revealed surprising structural conservation despite considerable sequence diversity (3). Thus, the parasite does not attempt to evade the immune response by gross structural change but instead generates antigenic variation through extensive alterations in the primary sequence. Sequence diversity in VSGs expressed by a given clone during the course of infection is far greater than that seen in virus systems where immune selection is primarily antibody mediated (24, 25, 34) . This has given rise to the belief that antigenic variation in VSGs may also be influenced by pressure from T-cell responses, which would require changes over the entire length of the molecule (3).
We have reported previously on the analysis of bovine T-cell responses to ILTat 1.3 VSG formulated in complete Freund's adjuvant (18) . We have now examined the specificity of these responses by using VSG gene deletions expressed in Escherichia coli. We show that the determinants recognized by a panel of seven VSG-specific CD4+ T-cell clones restricted by the same major histocompatibility complex (MHC) haplotype lie in areas of the molecule that are unconserved, providing support for the belief that T-cell pressure may contribute to antigenic variation in African trypanosomes.
MATERIALS AND METHODS
Antigen and T-cell clones. The VSG of T. brucei clone ILTat 1.3 was purified as described previously (9) and formulated in complete Freund's adjuvant to immunize Boran cattle at a dose of 200 ,ug per animal. The generation and characterization of bovine VSG-specific CD4+ T-cell clones have been described previously (18 (16) . Miniplasmid preparations of transformed colonies were prepared by the alkaline lysis method as described previously (27) and assessed for insert size by restriction enzyme analysis. A range of deletions was selected on the basis of size for screening with T-cell clones. Preparation of recombinant antigen. The expressed products of the VSG gene and its deletion derivatives in pGEX and pGUCIII were prepared essentially as described previously (29) . Briefly, overnight 50-ml cultures of E. coli JM109 transformed with recombinant plasmids were diluted 1:10 in fresh 2x YT medium (27) and incubated for a further 1 h at 37°C before the addition of isopropyl-3-D-thiogalactopyranoside (IPTG) to a final concentration of 0.1 mM. After an additional 2 h of culture, the cells were pelleted and resuspended in 10 ml of Dulbecco's phosphate-buffered saline (PBS). An equal volume of PBS containing 2% Triton X-100 was added, and the cells were sonicated on ice for 30 s. After the debris was pelleted by centrifugation at 10,000 x g for 5 min at 4°C, the supernatant was incubated for 5 min on a rolling platform with 1 ml of 50% reduced sulfur-linked glutathione-agarose beads (Sigma). The beads were then collected by a brief centrifugation and washed three times in 50 ml of PBS before elution of the fusion protein by the addition of 1 bead volume of 50 mM Tris HCl (pH 8.0) containing 5 mM reduced glutathione. Expression of recombinant antigen was confirmed by SDSpolyacrylamide gel electrophoresis analysis, and eluted antigen was stored at -20°C before evaluation in T-cell assays.
Assays of T-cell proliferation. A panel of seven VSG-specific T-cell clones was used to screen the VSG deletion products. (Fig. 1) . Although viable deletions in the VSG gene could be produced in pGEX-2T by using this AatII site and the EcoRI cloning site, this strategy resulted in the removal of the intervening translational stop codons of the vector, with the result that the expressed products of the deletions contained plasmid-derived sequences. In one instance, a VSG-specific clone was observed to cross-react with translated plasmid sequences. An additional characteristic of the pGEX vectors that made them unsuitable for the screening strategy was the low copy number to which they replicate in E. coli, which made the generation of sequencing templates rather tedious. The modified vector pGUCIII was therefore constructed, on the basis of the pGEX-2T glutathione-Stransferase expression cassette and the higher-copy-number plasmid pUC19, incorporating restriction enzyme site modifi- cations appropriate to the generation of exonuclease III deletions. The ILTat 1.3 gene was cloned into this vector to make pGUCIII-VSG, which was used to generate a second series of nested VSG gene deletions (d2 series).
The expressed products of both deletion series were prepared and used to pulse ALVC for inclusion in proliferative assays with a number of VSG-specific T-cell clones. In cases where a given clone responded to one deletion but failed to respond to the next in the series, the 3'-terminal DNA sequence of both deletions was determined by using the IL04 and IL0221 sequencing primers. Results of representative experiments are summarized in Table 1 . CD4+ T-cell clones derived from two separate cattle homozygous for the same MHC haplotype fell into three groups on the basis of their recognition patterns of the deletions. Clones 293/17 and 98/34 recognized deletion dl.6 but failed to recognize d2.10. These deletions differ in sequences that encode a fragment of the VSG molecule from amino acid residues 254 to 267. The epitope of clones 293/10 and 293/19 was delineated by deletions dl.5 and d2.7, corresponding to residues 363 to 383 of the antigen. The third group was represented by clone 98/7, which recognized d2.7 but not d2.8, indicating that its epitope contains sequences between residues 345 and 362 of the VSG molecule. These regions were designated Ti, T2, and T3, respectively (Fig. 2) . The recognition sites of an additional two clones, 293/2 and 293/23, were contained in deletions d2. 6 (lacking residues beyond amino acid 412) and dl.5 (lacking residues beyond amino acid 383), respectively (data not shown), but further resolution of the epitopes of these clones was precluded by their loss during the course of the study. All of the clones recognized the intact gene expressed from either pGEX2T or pGUCIII plasmids and the soluble antigen prepared from isolated trypanosomes and failed to proliferate in the absence of antigen.
DISCUSSION
We have defined three areas of the ILTat 1.3 VSG molecule that contain T-cell epitopes by using a nested series of truncated gene products generated by digestion with exonuclease III. One of these areas, designated Ti, is only 14 amino acids in length (Leu-254 to Ala-267). A second T-cell determinant was located to a stretch of 18 amino acids (T2; Thr-345 to Asp-362), while a third was found in a segment of 21 residues (T3; Leu-363 to Thr-383) (Fig. 2) .
With the availability of recent structural information on class A VSG molecules, both the Ti and T3 regions can be seen to map to the a-helical structures designated D and S, respectively (3). The T2 sequences occur in a loop structure adjacent to the S at-helix. The value of amphipathic helical propensity in the prediction of T-cell epitopes from protein sequences is well established (2, 10) , although crystallographic analysis of the antigen-binding cleft of the human class I and class II MHC molecules (4, 14, 15) has indicated that processed peptides held in the cleft do not actually adopt this structure. It is not clear how accurately the Ti, T2, and T3 regions delineate epitope sequences within the ILTat 1.3 molecule. The stretches were identified on the basis of the abrogation of T-cell recognition by deletion of gene sequences, and loss of recognition may have resulted from only partial deletion of the epitope. It has recently been determined that anchor residues on immunogenic peptides are crucially important for their association with MHC molecules (15) , and it is likely that It is not known whether translation commences at Met-1 or Met-9, although it is probable that the 16 hydrophobic residues that follow the latter constitute the N-terminal signal peptide (23) . The arrow indicates the site at which the VSG molecule is fused to glutathione-S-transferase on both pGEX and pGUC constructs. The solid bar indicates the beginning of the hydrophobic tail, which is not present in the mature protein used to immunize the cattle.
removal of these from an antigen fragment would adversely affect its immunogenicity. Thus, the epitopes of these clones may contain sequences upstream of the regions determined in this study. It is therefore possible that the T2 and T3 epitopes overlap, although they clearly constitute distinct specificities. Nonetheless, these considerations can only extend the possible location of the epitope by the length of a class II MHCassociated peptide, which has been determined in elution studies to be approximately 13 to 17 residues (26). Although it was not possible to map the epitopes of two of the clones included in the study, it was clear that all clones recognized areas in the nonconserved N-terminal domain of the molecule.
Although synthetic overlapping peptides can provide more precise definition, the use of 3' gene deletions constitutes a rapid and inexpensive means of locating T-cell epitopes in recombinant antigens. A similar approach to that used in this study was described by Crisanti and others (7) derived from pGEX-VSG. Although pGUCIII does not contain the lacIq repressor, we did not experience leakage of antigen expression from this plasmid in the absence of IPTG in E. coli JM109 or XL1-Blue (data not shown). Both of these strains carry the laqIq gene on an F' element, and expression of the repressor from the element was sufficient to suppress the tac promoter in our experiments. In the event that other constructs were to prove problematical in this aspect, additional copies of laqIq could be provided in trans by using a compatible plasmid such as pACYC184 (6) .
Recent conformational analysis of two class A VSG molecules has indicated that the enormous sequence diversity among these antigens is not associated with gross structural alteration (3). The great excess of this diversity over that seen in virus antigens under immune pressure from specific antibody responses (25, 34) has prompted the suggestion that it may be the result of pressure from T-cell responses (3 (1, 17) , immune pressure exerted by class II MHC-restricted T cells differs in that it is also exerted through the epitopes of B cells that benefit from T-cell help. Thus, a single conserved T-cell epitope on a newly emerged VSG could give rise to T-cell help for the entire array of new B-cell specificities on the molecule. This combined pressure might be too great to be dealt with through point mutations and may necessitate a more dramatic mechanism for diversity.
